News

Filter

Current filters:

FrancePharmaceutical

1 to 9 of 66 results

Sanofi could name Bayer's Olivier Brandicourt as new chief executive, sources say

Sanofi could name Bayer's Olivier Brandicourt as new chief executive, sources say

16-02-2015

Sources say that Olivier Brandicourt, the current head of healthcare at German drug major Bayer, is the…

BayerFranceManagementPharmaceuticalSanofi

Genzyme to cut 100 jobs as part of ongoing Sanofi restructure

Genzyme to cut 100 jobs as part of ongoing Sanofi restructure

12-02-2015

French drug major Sanofi has announced it is to cut around 100 research and development positions from…

FranceGenzymeManagementPharmaceuticalResearchSanofi

Ipsen reports strong performance by specialty care and solid overall growth for 2014

Ipsen reports strong performance by specialty care and solid overall growth for 2014

03-02-2015

French drugmaker Ipsen has reported solid growth for 2014, driven by good performance in its specialty…

DecapeptylDysportFinancialFranceIpsenPharmaceuticalSomatuline

Ipsen's Dysport gives positive results in adult and pediatric lower limb spasticity

Ipsen's Dysport gives positive results in adult and pediatric lower limb spasticity

26-01-2015

French drugmaker Ipsen has announced top line results from two double-blind Phase III trials of Dysport…

CNS DiseasesDysportFranceIpsenPharmaceuticalResearch

IN FOCUS: Nanobiotix CEO Laurent Levy explains the many benefits of nanomedicine

IN FOCUS: Nanobiotix CEO Laurent Levy explains the many benefits of nanomedicine

05-01-2015

Nanotechnology is poised to become the ‘next big thing’ in global health care. While big pharma companies…

FranceNanobiotixOncologyPharmaceuticalResearch

Strong top-line results for Poxel’s antidiabetic agent imeglimin

Strong top-line results for Poxel’s antidiabetic agent imeglimin

17-12-2014

France-based drug developer Poxel says that imeglimin, a novel compound in development to treat type…

DiabetesFranceHealthimegliminMerck SeronoPharmaceuticalPoxelResearch

Ipsen appoints François Garnier as executive vice president, general counsel

Ipsen appoints François Garnier as executive vice president, general counsel

17-12-2014

French drugmaker Ipsen has appointed François Garnier as executive vice president, general counsel of…

BoardroomFranceIpsenIpsen GroupPharmaceutical

Ipsen Phase III trial shows benefits of combining tamoxifen and triptorelin in breast cancer survival

Ipsen Phase III trial shows benefits of combining tamoxifen and triptorelin in breast cancer survival

12-12-2014

French drugmaker Ipsen has announced results of a trial evaluating the use of ovarian suppression as…

DecapeptylFranceIpsenOncologyPharmaceuticalResearchtamoxifentriptorelin pamoate

1 to 9 of 66 results

Back to top